OLMA
Olema Pharmaceuticals Inc.
$8.97
+$0.19(+2.16%)
59
Overall
60
Value
58
Tech
--
Quality
Market Cap
$560.74M
Volume
1.28M
52W Range
$2.86 - $13.51
Target Price
$24.38
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $71.5M | $107.0M | $105.0M | $142.3M | ||
| Research & Development | $51.1M | $82.3M | $86.1M | $124.5M | ||
| Research Expense | $51.1M | $82.3M | $86.1M | $124.5M | ||
| Selling, General & Administrative | $20.4M | $24.7M | $18.8M | $17.7M | ||
| General & Administrative Expenses | $20.4M | $24.7M | $18.8M | $17.7M | ||
| Salaries & Wages | -- | -- | $17.3M | $22.6M | ||
| Other Operating Expenses | $1.4M | $1.6M | $1.6M | $1.5M | ||
| OPERATING INCOME | ||||||
| Operating income | $-71.5M | $-107.0M | $-105.0M | $-142.3M | ||
| EBITDA | $-69.4M | $-106.6M | $-101.1M | $-136.5M | ||
| NON-OPERATING ITEMS | ||||||
| Intinc | $442.0K | $2.2M | $8.3M | $12.7M | ||
| Net Non-Operating Interest Income/Expense | $442.0K | $2.2M | $8.3M | $12.7M | ||
| Other Income/Expense | $47.0K | $-27.0K | $19.0K | $-102.0K | ||
| Other Special Charges | $-47.0K | $-27.0K | $-19.0K | $102.0K | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-71.1M | $-107.0M | $-102.8M | $-138.0M | ||
| Pre-Tax Income | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
| INCOME TAX | ||||||
| Tax Provision | $-25.0K | $-6.7M | $-6.1M | $-8.6M | ||
| NET INCOME | ||||||
| Net Income | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
| Net Income (Continuing Operations) | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
| Net Income (Discontinued Operations) | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
| Net Income (Common Stockholders) | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
| Normalized Income | -- | -- | -- | $-138.0M | ||
| TOTALS | ||||||
| Total Expenses | $71.5M | $107.0M | $105.0M | $142.3M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $39.5M | $40.0M | $45.2M | $58.7M | ||
| Average Shares Outstanding (Diluted) | $39.5M | $40.0M | $45.2M | $58.7M | ||
| Shares Outstanding | $40.3M | $40.6M | $55.9M | $68.3M | ||
| Basic EPS | $-1.8 | $-2.62 | $-2.14 | $-2.2 | ||
| Basic EPS (Continuing Operations) | $-1.8 | $-2.62 | $-2.14 | $-2.2 | ||
| Diluted EPS | $-1.8 | $-2.62 | $-2.14 | $-2.2 | ||
| Diluted EPS (Continuing Operations) | $-1.8 | $-2.62 | $-2.14 | $-2.2 | ||
| OTHER METRICS | ||||||
| Other Gand A | $20.4M | $24.7M | $18.8M | $17.7M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OLMA | $8.97 | +2.2% | 1.28M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Olema Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW